Unichem Laboratories to hold 63rd AGM on August 11, 2026
Unichem Laboratories will hold its 63rd AGM on August 11, 2026, via VC/OAVM. The agenda includes approving FY26 financial statements and re-appointing Mr. Pabitrakumar Bhattacharyya as MD & CEO for three years from August 10, 2026. His remuneration includes ₹20 lakh/month basic salary and other benefits. The AGM will also ratify the appointment of cost auditors for FY27 at ₹6 lakh.
The re-appointment of the MD & CEO for a further term and the associated remuneration details are material information for stakeholders. The AGM also involves the approval of financial statements and auditor remuneration, which are standard corporate governance procedures but have a medium-term impact on investor confidence and company operations.
The announcement is a routine notice for an Annual General Meeting and related business, including the re-appointment of the MD & CEO and ratification of cost auditors. While the re-appointment and remuneration details are provided, they do not indicate a significant positive or negative shift in the company's performance or outlook.
Unichem Laboratories Limited will convene its 63rd Annual General Meeting (AGM) on Tuesday, August 11, 2026, at 3:30 p.m. IST. The meeting will be conducted through Video Conference (VC) / Other Audio-Visual Means (OAVM). The AGM agenda includes receiving and adopting the audited standalone and consolidated financial statements for the financial year ended March 31, 2026, along with the reports of the Board of Directors and Auditors.
Furthermore, the meeting will address the re-appointment of Mr. Pabitrakumar Bhattacharyya as a Director retiring by rotation. A special business resolution proposes the re-appointment of Mr. Pabitrakumar Bhattacharyya as the Managing Director (MD) and Chief Executive Officer (CEO) for a further period of three years, effective from August 10, 2026, subject to member approval. The proposed remuneration includes a basic salary of ₹20,00,000 per month, a commission not exceeding 1% of net profits, and various perquisites such as house rent allowance, medical expenses, and leave travel concession.
An ordinary resolution will also be considered to ratify the remuneration payable to Kishore Bhatia & Associates, Cost Accountants, for auditing the company's cost records for the financial year ending March 31, 2027, amounting to ₹6,00,000 plus applicable taxes and expenses. The company has provided detailed instructions for remote e-voting, which begins on Friday, August 7, 2026, and ends on Monday, August 10, 2026.
What to do with a filing like this
Unichem Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Unichem Laboratories Limited. Read the original for the full detail.